Lemon8Lifestyle community
microbialschoolbus
microbialschoolbus

298 followers

Follow
Follow
Follow
A news article from November 2023 highlights that drug shortages, particularly in oncology, have been a persistent problem in the U.S. for years.
An ABC News article from February 2012 reports a critical shortage of children's leukemia drugs, noting that cancer drug limitations have led to rationing and inconsistent treatment for years.
A news headline warns of a two-week supply crisis for life-saving childhood leukemia drugs, attributing limited drug supply to profit margins.
An October 2011 article states President Obama issued an executive order to curb prescription drug shortages, aiming to prevent future supply issues.
Text explains that antibiotics and oncology drugs are less profitable for pharmaceutical companies than drugs like Lipitor or Viagara because patients use them for shorter durations, contributing to shortages.
A July 2012 Houston Chronicle article discusses legislation to provide incentives for pharmaceutical firms to develop child cancer drugs, addressing a chronic mismatch in drug development.
A WHO report from September 2017 confirms a global shortage of antibiotics, noting that oncology drugs are not the only concern, with resistance and lack of development contributing to the antibiotic crisis.
1/8

You may also like

No content
See more on the app
See more on the app
See more on the app
4 saved
3
10

When profits come before patients…

2024/12/15 Edited to

... Read moreI've been watching the news lately, and one topic that really hits home is the ongoing crisis of drug shortages. It's not just a headline; it impacts real lives, and honestly, it makes you wonder where our priorities lie when it comes to healthcare. We're talking about essential medicines, especially for serious conditions like cancer and common infections, becoming incredibly scarce. It seems the core issue often boils down to economics. According to various reports I've seen, pharmaceutical companies find certain drugs, like many antibiotics and oncology treatments, less profitable compared to blockbuster drugs like Lipitor or Viagra. Why? Because patients might use them for shorter durations, meaning less long-term revenue. This stark reality means that sometimes, the focus on profit margins can overshadow the pressing need for life-saving medications. We've seen the devastating consequences of this. I remember reading about the critical shortage of children's leukemia drugs back in 2012, leading to rationing and inconsistent treatment options for vulnerable children. Imagine the anguish of parents knowing a treatment exists but isn't available due to supply issues. More recently, in November 2023, reports highlighted that these drug shortages, particularly in oncology, have been a persistent problem in the U.S. for years. It's not a new issue, but one that keeps resurfacing. It's not that no one has tried to address this. Back in October 2011, President Obama even issued an executive order to curb prescription drug shortages, aiming to prevent future supply issues. There have also been discussions about legislation, like the Houston Chronicle reported in 2012, aiming to provide incentives for pharmaceutical firms to develop child cancer drugs. These efforts show an awareness of the problem, but clearly, it's a deeply entrenched systemic issue. And it's not just cancer; a WHO report from 2017 confirmed a global shortage of antibiotics, with concerns about resistance and lack of development contributing to that crisis too. So, what does this all mean for us? It means we need to ask tough questions about how our healthcare system is structured and whether patient well-being truly comes first. When profits come before patients, the most vulnerable often suffer. It's a complex challenge, but raising awareness and advocating for policies that prioritize public health over pure financial gain is a crucial starting point. What are your thoughts on this critical issue?